JPH03291208A - Cosmetic - Google Patents
CosmeticInfo
- Publication number
- JPH03291208A JPH03291208A JP9256190A JP9256190A JPH03291208A JP H03291208 A JPH03291208 A JP H03291208A JP 9256190 A JP9256190 A JP 9256190A JP 9256190 A JP9256190 A JP 9256190A JP H03291208 A JPH03291208 A JP H03291208A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- cosmetic
- preparation example
- hair
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 48
- 239000000284 extract Substances 0.000 claims abstract description 88
- 210000001835 viscera Anatomy 0.000 claims abstract description 28
- 108091005804 Peptidases Proteins 0.000 claims abstract description 13
- 102000035195 Peptidases Human genes 0.000 claims abstract description 6
- 241000237858 Gastropoda Species 0.000 claims description 17
- 230000000694 effects Effects 0.000 abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 26
- 102000003425 Tyrosinase Human genes 0.000 abstract description 13
- 108060008724 Tyrosinase Proteins 0.000 abstract description 13
- -1 lipid peroxide Chemical class 0.000 abstract description 10
- 238000003287 bathing Methods 0.000 abstract description 5
- 108090000631 Trypsin Proteins 0.000 abstract description 4
- 102000004142 Trypsin Human genes 0.000 abstract description 4
- 239000012588 trypsin Substances 0.000 abstract description 4
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 102000057297 Pepsin A Human genes 0.000 abstract description 2
- 108090000284 Pepsin A Proteins 0.000 abstract description 2
- 229940111202 pepsin Drugs 0.000 abstract description 2
- 241000237373 Aplysia sp. Species 0.000 abstract 2
- 238000013329 compounding Methods 0.000 abstract 2
- 235000019833 protease Nutrition 0.000 abstract 2
- 230000003064 anti-oxidating effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 description 47
- 239000000203 mixture Substances 0.000 description 32
- 238000009472 formulation Methods 0.000 description 27
- 239000000243 solution Substances 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 20
- 238000004519 manufacturing process Methods 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 239000007787 solid Substances 0.000 description 16
- 239000000843 powder Substances 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- 239000008213 purified water Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 235000011187 glycerol Nutrition 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000019441 ethanol Nutrition 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- 239000004365 Protease Substances 0.000 description 8
- 241000894431 Turbinidae Species 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 235000019419 proteases Nutrition 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 230000009278 visceral effect Effects 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 239000013040 bath agent Substances 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 241000237967 Aplysia Species 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 206010044625 Trichorrhexis Diseases 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 239000003974 emollient agent Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000002453 shampoo Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 3
- 239000002932 luster Substances 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000014593 oils and fats Nutrition 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 240000008574 Capsicum frutescens Species 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000006981 Skin Abnormalities Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 239000003676 hair preparation Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- NJYFRQQXXXRJHK-UHFFFAOYSA-N (4-aminophenyl) thiocyanate Chemical compound NC1=CC=C(SC#N)C=C1 NJYFRQQXXXRJHK-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- LIFHMKCDDVTICL-UHFFFAOYSA-N 6-(chloromethyl)phenanthridine Chemical compound C1=CC=C2C(CCl)=NC3=CC=CC=C3C2=C1 LIFHMKCDDVTICL-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 239000004604 Blowing Agent Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 108090001069 Chymopapain Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ISWQCIVKKSOKNN-UHFFFAOYSA-L Tiron Chemical compound [Na+].[Na+].OC1=CC(S([O-])(=O)=O)=CC(S([O-])(=O)=O)=C1O ISWQCIVKKSOKNN-UHFFFAOYSA-L 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000037374 absorbed through the skin Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960002976 chymopapain Drugs 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- JZKFHQMONDVVNF-UHFFFAOYSA-N dodecyl sulfate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCCCCCCOS(O)(=O)=O JZKFHQMONDVVNF-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- GIQAZSIUJMRIFW-NBTZWHCOSA-N ethanol;(9z,12z)-octadeca-9,12-dienoic acid Chemical compound CCO.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O GIQAZSIUJMRIFW-NBTZWHCOSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L magnesium sulphate Substances [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は化粧料に関する。さらに詳しくは、基礎化粧品
をはじめ、メイクアップ化粧品、頭髪用化粧品、浴剤な
どに好適に使用しうる化粧料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to cosmetics. More specifically, the present invention relates to cosmetics that can be suitably used in basic cosmetics, make-up cosmetics, hair cosmetics, bath additives, and the like.
[従来の技術]
従来より、すぐれたモイスチャー効果やエモリエント効
果を皮膚に付与し、チロシナーゼの活性を抑制し、かつ
過酸化脂質の生成を抑制し、保湿、美白モして老化防止
効果などの総合的な化粧効果を発現する化粧料の開発が
待ち望まれている。[Conventional technology] Conventionally, it has been used to provide excellent moisturizing and emollient effects to the skin, inhibiting tyrosinase activity and lipid peroxide production, and has comprehensive effects such as moisturizing, whitening, and anti-aging effects. The development of cosmetics that exhibit unique cosmetic effects is eagerly awaited.
そこで、皮膚からの吸収がよく、生理活性物質を皮膚に
補給することにより皮膚の新陳代謝を活性化させる化粧
料として、特開昭59−iioeos号公報や特開昭5
9−95210号公報に記載された化粧料が提案されて
いる。Therefore, as a cosmetic that is easily absorbed through the skin and activates skin metabolism by supplying physiologically active substances to the skin, JP-A-59-IIOEOS and JP-A-5
A cosmetic described in Japanese Patent No. 9-95210 has been proposed.
しかしながら、これらの公報に記載された化粧料は、い
ずれも確かに皮膚の新陳代謝を活性化する効果を発現す
るものであるが、チロシナーゼの活性を抑制し、過酸化
脂質の生成を抑制し、保湿効果、美白効果および老化防
止効果を同時に充分に発現するものではない。However, although the cosmetics described in these publications do indeed have the effect of activating skin metabolism, they suppress tyrosinase activity, suppress the production of lipid peroxide, and have a moisturizing effect. However, it does not sufficiently exhibit the whitening effect and anti-aging effect at the same time.
[発明が解決しようとする課題]
そこで本発明者らは、前記従来技術に鑑みてシミ、ソバ
カスに有効なすぐれたモイスチャー効果やエモリエント
効果を皮膚に付与し、チロシナーゼの活性を抑制して過
酸化脂質の生成【抑制し、保湿効果、美白効果および老
化防止効果を同時に発揮する化粧料をうることを目的と
して鋭意研究を重ねた結果、意外なことに、腹足類の内
臓からえられた抽出物は、これらの効果をすべて同時に
発揮し、さらにはかかる抽出物が頭髪保護効果および浴
剤としての保温効果を発揮することを見出し、本発明を
完成するにいたった。[Problems to be Solved by the Invention] In view of the above-mentioned prior art, the present inventors have provided the skin with excellent moisturizing and emollient effects that are effective against age spots and freckles, suppressing the activity of tyrosinase and reducing peroxidation. As a result of extensive research aimed at producing cosmetics that simultaneously inhibit lipid production and exhibit moisturizing, whitening, and anti-aging effects, we unexpectedly discovered that an extract obtained from the internal organs of gastropods... We have now completed the present invention by discovering that all of these effects are exhibited simultaneously, and that this extract also exhibits a hair-protecting effect and a heat-retaining effect as a bath additive.
[課題を解決するための手段]
すなわち、本発明は腹足類の内臓からえられた抽出物が
配合されてなる化粧料に関する。[Means for Solving the Problems] That is, the present invention relates to a cosmetic containing an extract obtained from the internal organs of gastropods.
[作用および実施例]
本発明に用いられる腹足類の内臓からえられた抽出物中
の成分については未だ定かではないが、本発明者らの研
究によれば、該抽出物中に各種アミノ酸、少糖類、多糖
類などが含まれていることが確認されている。そして、
これらの各種成分が、本発明において目的とする化粧効
果を発現するものと思われる。[Operations and Examples] The components of the extract obtained from the internal organs of gastropods used in the present invention are not yet clear, but according to the research of the present inventors, various amino acids and a few It has been confirmed that it contains sugars and polysaccharides. and,
It is believed that these various ingredients exert the cosmetic effects aimed at in the present invention.
本発明に用いられる腹足類としては、たとえばアワビ、
サザエ、トコブシ、ツメタガイ、タマキビ、ホラガイ、
アメフラシ、ラミウシ、タニシ、カタツムリ、ナメクジ
などがあげられるが、本発明はかかる例示のみに限定さ
れるものではない。なお、これらの腹足類のなかでは、
アワビ、サザエおよびアメフラシは、とくに個体重量に
おける内臓部の歩留まりが比較的大きいので好ましいも
のである。Examples of gastropods used in the present invention include abalone,
Turban shell, tokobushi, turban shell, tamakibi, conch shell,
Examples include Aplysia, lamina, snails, snails, slugs, etc., but the present invention is not limited to these examples. Furthermore, among these gastropods,
Abalone, turban shell, and Aplysia are particularly preferable because the yield of internal organs in terms of individual weight is relatively high.
本発明に用いられる腹足類の内臓からえられた抽出物と
しては、たとえば新鮮な腹足類や新鮮な状態で冷凍され
た腹足類むどの内臓を抽出用の溶媒に浸漬し、抽出する
ことによりえられた抽出液、該抽出液が濃縮された濃縮
抽出液、前記抽出液を凍結乾燥またはスプレードライし
てえられる粉体、顆粒や粒子状物などがあげられ、本発
明はかかる抽出物の形態によって限定されるものではな
い。Extracts obtained from internal organs of gastropods used in the present invention include, for example, extracts obtained by immersing fresh gastropods or freshly frozen internal organs of gastropods in an extraction solvent and extracting them. liquid, a concentrated extract obtained by concentrating the extract, powder obtained by freeze-drying or spray-drying the extract, granules, particulates, etc., and the present invention is not limited by the form of such extract. It's not something you can do.
前記抽出物を調製する方法としては、種々の方法がある
が、その方法の一例をあげれば、たとえば腹足類の内臓
を細切りし、これを後述する抽出用の溶媒に浸漬し、加
温しなから抽出する方法などかあげられるが、本発明は
かかる方法に限定されるものではない。There are various methods for preparing the extract, but one example is to cut the internal organs of a gastropod into small pieces, immerse them in the extraction solvent described below, and then heat them. Although the present invention is not limited to such a method, the present invention is not limited to such a method.
前記抽出用の溶媒としては、たとえば水:メタノール、
エタノールなとの低級アルコール類:エチレングリコー
ル、プロピレングリコール、グリセリン、1.3−ブチ
レングリコールなどのポリオール類;オレイルアルコー
ル、ステアリルアルコール、オクチルドデカノールなど
の高級アルコール類:アセトンなどのケトン類:酢酸エ
チルなどのエステル類;ヘキサン、ジクロロメタン、ベ
ンゼン、トルエン、エーテル類などの炭化水素系溶剤な
どがあげられ、これらは単独でまたは2種以上を混合し
て用いられる。これらのなかでは化粧料への幅広い適用
という点で水または水溶性の溶剤が好ましく、なかでも
とくに水、エタノール、グリセリン、1.3−ブチレン
グリコールが好ましい。Examples of the extraction solvent include water:methanol,
Lower alcohols such as ethanol: Polyols such as ethylene glycol, propylene glycol, glycerin, and 1,3-butylene glycol; Higher alcohols such as oleyl alcohol, stearyl alcohol, and octyldodecanol; Ketones such as acetone: Ethyl acetate and hydrocarbon solvents such as hexane, dichloromethane, benzene, toluene, and ethers, and these may be used alone or in combination of two or more. Among these, water or water-soluble solvents are preferred from the viewpoint of wide application to cosmetics, and water, ethanol, glycerin, and 1,3-butylene glycol are particularly preferred.
なお、本究明において、抽出の際にはたとえばトリプシ
ン、ペプシン、アクチナーゼ、グリンルグリシンベブチ
ターセ、カルボキシベプチターゼ、アミノペブチターゼ
、パパイン、プロメライン、キモパパイン、キモトリプ
シンなどの蛋白分解酵素により、抽出物に処理か施され
ることか、さらにチロシナーゼの活性を抑、1;II
L、かつ過酸化脂質の生成を抑制するという作用を呈す
るうえで好ましい。なお、前記蛋白分解酵素の使用量は
、前記腹足類の内臓100部(重量部、以下同様)に対
して0.01〜10部、なかんづ<0.1〜1部である
ことが好ましい。かかる使用量が前記範囲未満であるば
あい、蛋白の分解か不充分とムリ、前記抽出物が有する
作用効果が減少する傾向かあり、また前記範囲をこえる
ばあい、必要量以上の添加は、酵素の特性から考えても
意味がない。In this study, during extraction, for example, proteolytic enzymes such as trypsin, pepsin, actinase, glycolglycine bebutitase, carboxybeptidase, aminopebutitase, papain, promelain, chymopapain, and chymotrypsin were used. Treatment of the extract further suppresses tyrosinase activity, 1; II
L, and is preferable because it exhibits the effect of suppressing the production of lipid peroxide. The amount of the protease used is preferably 0.01 to 10 parts, preferably <0.1 to 1 part, based on 100 parts (parts by weight, hereinafter the same) of the internal organs of the gastropod. If the amount used is less than the above range, protein decomposition may be insufficient and the effects of the extract will tend to decrease; if the amount exceeds the above range, adding more than the necessary amount It makes no sense considering the characteristics of the enzyme.
抽出時間は、溶媒の種類や抽出温度などにより異なるた
め、−概には決定することができないが、通常1〜48
時間、好ましくは3〜12時間である。また、抽出温度
は溶媒の種類などにより異なるため、−概には決定する
ことができないが、0℃以上であればよく、通常30〜
70℃であることが適当である。The extraction time varies depending on the type of solvent and extraction temperature, so it cannot be determined generally, but it is usually between 1 and 48
time, preferably 3 to 12 hours. In addition, since the extraction temperature varies depending on the type of solvent, etc., it cannot be determined generally, but it should be 0°C or higher, and usually 30°C or higher.
A suitable temperature is 70°C.
なお、えられた抽出液は、皮膚への安全性の点からpH
が4〜8程度に調整されることが好ましい。In addition, the pH of the obtained extract was adjusted to ensure safety for the skin.
is preferably adjusted to about 4 to 8.
かくしてえられる抽出物は、ヒトの肌に対してすぐれた
保湿作用、チロシナーゼ活性抑制作用によるメラニン生
成抑制作用および抗酸化作用による過酸化脂質生成抑制
作用を有し、さらには湯に投入したばあいには入浴時や
入浴後の体温の保温維持作用にすぐれたものである。The extract obtained in this way has an excellent moisturizing effect on human skin, an effect of suppressing melanin production by suppressing tyrosinase activity, and a suppressing effect of lipid peroxide production by antioxidant effect, and furthermore, when added to hot water, It has an excellent ability to maintain body temperature during and after bathing.
本発明の化粧料は、前記抽出物が配合されたものである
。前記抽出物の化粧料への配合量は、化粧料の種類など
により異なるので一概には決定することができないが、
その−例をあげれば、たとえば化粧料100部に対して
抽出物の固形分0.05〜90部、好ましくはo、i〜
10部であることが望ましい。かかる配合量は前記範囲
未満であるばあいには、前記抽出物を配合したことによ
る効果が小さくなる傾向があり、また前記範囲をこえる
ばあいには、それ以上の効果の向上は望めない。The cosmetic of the present invention contains the above-mentioned extract. The amount of the extract to be incorporated into cosmetics cannot be determined unconditionally as it varies depending on the type of cosmetics, etc.
For example, the solid content of the extract is 0.05 to 90 parts per 100 parts of the cosmetic, preferably o, i to
Preferably 10 parts. If the blending amount is less than the above-mentioned range, the effect of blending the extract tends to be reduced, and if it exceeds the above-mentioned range, no further improvement in the effect can be expected.
本発明の化粧料の形態は任意であり、たとえばクリーム
、乳液、化粧水、固形状の化粧料などの形態があげられ
る。The form of the cosmetic of the present invention is arbitrary, and includes, for example, a cream, a milky lotion, a lotion, a solid cosmetic, and the like.
また、前記抽出物は、前記のごとく、湯に投入したばあ
いに体温の保持効果にすぐれていることから、本発明の
化粧料は浴剤として好適に使用しうるものである。この
ように本発明の化粧料を浴剤として使用するばあいには
、抽出物の化粧料への配合量は、化粧料100部に対し
て抽出物の固形分換算で0.1〜90部、好ましくは0
.1−10部とすることが望ましい。前記浴剤を使用す
るばあいには、該溶剤の使用量は、通常湯200gに対
して浴剤を5〜25g程度となるように調整されること
が好ましい。Further, as mentioned above, the extract has an excellent effect of retaining body temperature when added to hot water, so the cosmetic composition of the present invention can be suitably used as a bath agent. When the cosmetic of the present invention is used as a bath additive, the amount of the extract added to the cosmetic is 0.1 to 90 parts in terms of solid content of the extract per 100 parts of the cosmetic. , preferably 0
.. It is desirable to use 1-10 parts. When using the bath agent, the amount of the solvent used is preferably adjusted to about 5 to 25 g per 200 g of normal hot water.
本発明の化粧料は、前記抽出物を含有したものであるが
、該抽出物の他にたとえば一般に化粧料に用いられてい
る賦形剤、香料などをはじめ、油脂類、界面活性剤、保
湿剤、pH1)tl整剤、増粘剤、防腐剤、酸化防止剤
、紫外線吸収剤などの各種化粧料成分が適宜配合される
。The cosmetic of the present invention contains the above-mentioned extract, but in addition to the extract, it also contains, for example, excipients and fragrances commonly used in cosmetics, oils and fats, surfactants, and moisturizers. Various cosmetic ingredients such as a pH 1) regulator, a thickener, a preservative, an antioxidant, and an ultraviolet absorber are appropriately blended.
前記油脂類としては、一般に化粧料に汎用されるたとえ
ばパラフィン、セタノール、アボガド油、オリーブ油、
ホホバ油、ヤシ油などの植物性油;牛脂、豚脂、馬脂、
ターモル浦、ミンク油、パーセリン油などの動物性池脂
;トリカプリルカプリン酸グリセリン、トリオクタン酸
グリセリン、トリイソパルミチン酸グリセリン、シリコ
ーンオイルなどの合成油脂などがあげられる。Examples of the oils and fats include paraffin, cetanol, avocado oil, olive oil, etc., which are commonly used in cosmetics.
Vegetable oils such as jojoba oil and coconut oil; beef tallow, pork tallow, horse tallow,
Examples include animal fats such as Termolura, mink oil, and parcellin oil; synthetic oils and fats such as tricaprylcapric acid glycerin, trioctanoic acid glycerin, triisopalmitic acid glycerin, and silicone oil.
前記界面活性剤としては、たとえばラウリル硫酸ナトリ
ウム、ラウリル硫酸トリエタノールアミン、ラウリン酸
ジェタノールアミドなどの陰イオン性界面活性剤;ステ
アリルトリメチルアンモニウムクロライド、セチルトリ
メチルアンモニウムクロライド、塩化ベンザルコニウム
などの陽イオン性界面活性剤;グリセリルモノステアレ
ート、ソルビタンモノステアレート、ポリオキシエチレ
ン硬化ヒマシ油、ショ糖エステル、脂肪酸アミドなどの
非イオン性界面活性剤などがあげられる。Examples of the surfactant include anionic surfactants such as sodium lauryl sulfate, triethanolamine lauryl sulfate, and jetanolamide laurate; cationic surfactants such as stearyltrimethylammonium chloride, cetyltrimethylammonium chloride, and benzalkonium chloride; Nonionic surfactants such as glyceryl monostearate, sorbitan monostearate, polyoxyethylene hydrogenated castor oil, sucrose ester, fatty acid amide, etc.
前記保湿剤としては、たとえばグリセリン、プロピレン
グリコール、1.3−ブチレングリコール、ピロリドン
カルボン酸ソーダなどの合成保湿剤;ヒアルロン酸、コ
ラ−ケン、エラスチン、胎盤抽出液、ローヤルゼリー、
微生物発酵液などの天然保湿液などがあげられる。Examples of the moisturizing agent include synthetic moisturizing agents such as glycerin, propylene glycol, 1,3-butylene glycol, and sodium pyrrolidone carboxylate; hyaluronic acid, kolaken, elastin, placenta extract, royal jelly,
Examples include natural moisturizing liquids such as microbial fermentation liquid.
これらの化粧料成分の各配合量は目的とする化粧料の用
途などにより異なるため、−概には決定することができ
ず、用途に応じて適宜調整されることが好ましい。The amount of each of these cosmetic ingredients varies depending on the intended use of the cosmetic, and therefore cannot be determined generally, and is preferably adjusted as appropriate depending on the intended use.
かくしてえられる本発明の化粧料は、肌に潤いを与え、
シミ、ソバカス、シワなどを防止し、皮膚の老化を予防
するなどのすくれた性質を有するものであるので、たと
えばクリーム、乳液、ローション、洗顔料、パックなど
の基礎化粧品、口紅、ファンデーションなどのメイクア
ップ化粧品、ボディーソーブ、石鹸などのトイレタリー
製品、浴剤などの形態に調製して用いられる。The thus obtained cosmetic of the present invention moisturizes the skin,
It has the property of preventing spots, freckles, wrinkles, etc. and preventing skin aging, so it is used in basic cosmetics such as creams, emulsions, lotions, facial cleansers, packs, lipsticks, foundations, etc. It is prepared and used in the form of make-up cosmetics, body wash, toiletry products such as soap, bath salts, etc.
また、本発明の化粧料は頭髪に対しても毛根周辺の環境
改善および頭髪への直接的な作用により、枝毛や切れ毛
の防止、頭髪保護にも有効であるので、たとえばヘアー
トニック、ヘアーリキッド、ヘアーブロー剤、ヘアーセ
ットローション、ヘアークリームなどの頭髪用製品やシ
ャンプー リンス、ヘアートリートメントなどの頭髪用
トイレタリー製品に適宜調製することができるものであ
る。さらに、本発明の化粧料は、前記のごとく、浴剤と
しても好適に使用しうるちのである。In addition, the cosmetics of the present invention are effective for preventing split ends and hair breakage and protecting the hair by improving the environment around the hair roots and acting directly on the hair. It can be appropriately prepared into hair products such as liquid, hair blowing agent, hair setting lotion, and hair cream, and hair toiletry products such as shampoo conditioner and hair treatment. Furthermore, the cosmetic composition of the present invention can also be suitably used as a bath agent, as mentioned above.
つぎに本発明の化粧料を実施例に基づいてさらに詳細に
説明するが、本発明はががる実施例のみに限定されるも
のではない。Next, the cosmetics of the present invention will be explained in more detail based on Examples, but the present invention is not limited to the Examples.
調製例1(サザエの内臓抽出液の製造)新鮮なサザエか
ら貝殻および筋肉部を除いた内臓部5kgを細切りした
のち、弱アルカリ性に調整したクエン酸ナトリウム水溶
液3gに浸漬した。つぎに、この水溶液に蛋白分解酵素
としてトリプシン25gを添加し、55℃に加温しなが
ら約5時間抽出したのち、10?6乳酸水溶液を添加し
てpHを7.0に調整し、濾過精製して淡褐色の抽出物
(固形分含童約5重量%)約2kgをえた。Preparation Example 1 (Manufacture of turban shell viscera extract) 5 kg of the viscera of a fresh turban shell, excluding the shell and muscle, was cut into small pieces, and then immersed in 3 g of an aqueous sodium citrate solution adjusted to be slightly alkaline. Next, 25 g of trypsin as a proteolytic enzyme was added to this aqueous solution and extracted for about 5 hours while heating to 55°C. After that, a 10-6 lactic acid aqueous solution was added to adjust the pH to 7.0, and filtration and purification were performed. About 2 kg of a light brown extract (solid content: about 5% by weight) was obtained.
調製例2(トコブシの内臓抽出液の製造)サザエの内臓
部5kgのかわりに新鮮なトコブシから貝殻および筋肉
部を除いた内臓部5kgを用いたほかは調製例1と同様
にして淡褐色の抽出物(固形分含量約5重量%)約2k
gをえた。Preparation Example 2 (Production of visceral extract of tokobushi) A light brown extract was prepared in the same manner as in Preparation Example 1, except that 5 kg of the viscera of fresh tokobushi, with the shell and muscle parts removed, was used instead of 5 kg of the viscera of turban shell. Approximately 2k (solid content approximately 5% by weight)
I got g.
調製例3(アメフラシの内臓抽出液の製造)サザエの内
臓部5kgのかわりに新鮮なアメフラシから貝殻および
筋肉部を除いた内臓部1kgを用いたほかは調製例1と
同様にして淡褐色の抽出物(固形分含量約5重量%)約
2鰭をえた。Preparation Example 3 (Manufacture of Aplysia viscera extract) Light brown extraction was carried out in the same manner as in Preparation Example 1, except that 1 kg of fresh Aplysia viscera, with the shell and muscle parts removed, was used instead of 5 kg of turban shell viscera. About 2 fins (solid content about 5% by weight) were obtained.
調製例4 (アワビの内臓抽出液の製造)新鮮なアワビ
から貝殻および筋肉部を除いた内臓部5kgを細切りし
たのち、1.3−ブチレングリコールを(0%含有する
弱アルカリ性水溶液3gに浸漬した。かかる水溶液に蛋
白分解酵素としてトリプシン15gを添加し、60℃に
加温しなから約5時間抽出したのち、I O9ciリン
酸水溶液を添加してpi(を8.0に21整し、濾過精
製して淡褐色の抽出物(固形分含量約5重量%)約2k
gをえた。Preparation Example 4 (Manufacture of abalone viscera extract) After removing the shell and muscle parts from fresh abalone, 5 kg of the viscera was cut into small pieces, and then immersed in 3 g of a weakly alkaline aqueous solution containing 0% 1,3-butylene glycol. 15 g of trypsin as a proteolytic enzyme was added to the aqueous solution, heated to 60°C and extracted for about 5 hours, and then an aqueous solution of IO9ci phosphoric acid was added to adjust pi to 8.0, and filtered. Purified light brown extract (solid content approximately 5% by weight) approximately 2k
I got g.
調製例5(ラミウシの内臓抽出液の製造)アワビの内臓
部5kgのかオ〕りに新鮮なラミウシから筋肉部を除い
た内臓部1 kgを用いたほかは調製例4と同様にして
淡褐色の抽出物(固形分含量約5重量9゜)約2kgを
えた。Preparation Example 5 (Production of visceral extract of ramus slug) A pale brown visceral extract was prepared in the same manner as in Preparation Example 4, except that 1 kg of fresh ramus viscera, with the muscle part removed, was used instead of 5 kg of abalone viscera. Approximately 2 kg of extract (solid content: approximately 5 weight, 9°) was obtained.
調製例6(タニシの内臓抽出液の製造)アワビの内臓部
5kgのかわりに新鮮なタニシから筋肉部を除いた内臓
部1 kgを用いたはがば調製例4と同様にして淡褐色
の抽出物(固形分含量約5重量%)約2kgをえた。Preparation Example 6 (Manufacture of visceral extract of snail snail) Extract a light brown color in the same manner as in Preparation Example 4 using 1 kg of fresh snail viscera with the muscle part removed instead of 5 kg of abalone viscera. Approximately 2 kg of solids (solid content: approximately 5% by weight) was obtained.
調!!2例7(サザエの内臓抽出液の製造)調製例1に
おいて、蛋白分解酵素を用いないほかは調製例1と同様
にして淡褐色の抽出物(固形分含量約5重量96)約2
kgをえた。Tone! ! Example 2 Example 7 (Production of visceral extract of turban shell) A light brown extract (solid content: approximately 5 weight 96) was prepared in the same manner as in Preparation Example 1 except that no protease was used.
I gained kg.
調製例8(トコブシの内臓抽出液の製造)調製例2にお
いて、蛋白分解酵素を用いないほかは調製例2と同様に
して淡褐色の抽出物(固形分含量約5重量96)約2k
gをえた。Preparation Example 8 (Manufacture of Tokobushi viscera extract) A light brown extract (solid content: about 5 weight 96) was prepared in the same manner as Preparation Example 2 except that no protease was used.
I got g.
調製例9(アメフラシの内臓抽出液の製造)調製例3に
おいて、蛋白分解酵素を用いないほかは調製例2と同様
にして淡褐色の抽出物(固形分含量約5重量%)約2眩
をえた。Preparation Example 9 (Production of Aplysia Visceral Extract) In Preparation Example 3, a light brown extract (solid content of about 5% by weight) was prepared in the same manner as Preparation Example 2 except that no protease was used. I got it.
調製例10(アワビの内臓抽出液の製造)調製例4にお
いて、蛋白分解酵素を用いらいほかは調製例4と同様に
して淡褐色の抽出物(固形分含量約5重量%)約2嘘を
えた。Preparation Example 10 (Production of abalone viscera extract) In the same manner as in Preparation Example 4 except that the protease was used, a light brown extract (solid content of about 5% by weight) was prepared in the same manner as in Preparation Example 4. I got it.
調製例11(ラミウシの内臓抽出液の製造)調製例5に
おいて、蛋白分解酵素を用いないほかは調製例5と同様
にして淡褐色の抽出物(固形分含量約5重量%)約2k
gをえた。Preparation Example 11 (Production of visceral extract of Rami slug) A light brown extract (solid content: about 5% by weight) of about 2k was prepared in the same manner as in Preparation Example 5, except that no protease was used.
I got g.
調製例12(タニシの内臓抽出液の製造)調製例6にお
いて、蛋白分解酵素を用いないほかは調製例6と同様に
して淡褐色の抽出物(固形分含量約5重量 9o)約2
kgをえた。Preparation Example 12 (Production of snail viscera extract) A light brown extract (solid content: about 5 weight, 9 o) was prepared in the same manner as in Preparation Example 6, except that no protease was used.
I gained kg.
参考例1〜13
調製例1〜12でえられた抽出液をサンプルとして用い
て以下に示す試験を行なった。Reference Examples 1 to 13 The following tests were conducted using the extracts obtained in Preparation Examples 1 to 12 as samples.
0)チロシナーゼ活性抑制作用(チロシナーゼ反応法)
チロシナーゼ(2200単位)1.OBを正確に秤量し
、リン酸緩衝液(pH6,8) 2.0mlに溶解し
てチロシナーゼ溶液を調製した。0) Tyrosinase activity inhibition effect (tyrosinase reaction method) Tyrosinase (2200 units) 1. OB was accurately weighed and dissolved in 2.0 ml of phosphate buffer (pH 6, 8) to prepare a tyrosinase solution.
つぎに、各調製例でえられた内臓抽出液を10倍に希釈
した水溶液0.8mlを正確に秤量し、これに0.05
%L−チロシン溶液1.0mlおよびリン酸緩衝液(p
H6,8) 1.0mlを加えて充分に撹拌して混合
した。この液に前記チロシナーゼ溶液0.2mlを加え
て充分に撹拌して混合し、この溶液の波長475n−に
おける吸光度をただちに測定したのち、37℃の恒温槽
中に入れた。Next, 0.8 ml of an aqueous solution obtained by diluting the viscera extract obtained in each preparation example 10 times was weighed accurately, and 0.05
% L-tyrosine solution and 1.0 ml of phosphate buffer (p
1.0 ml of H6,8) was added and thoroughly stirred to mix. 0.2 ml of the above tyrosinase solution was added to this solution and mixed by thorough stirring. The absorbance of this solution at a wavelength of 475 n- was immediately measured, and then placed in a constant temperature bath at 37°C.
24分間経過後、恒温槽からこの溶液を取り出し、再び
波長475n■における吸光度を測定し、下式からチロ
シナーゼ活性指数を求めた。また、抽出液の代わりに水
を用いて同様に操作したものをブランクとした。その結
果を第1表に示す。After 24 minutes had elapsed, this solution was taken out from the thermostatic bath, the absorbance at a wavelength of 475 nm was measured again, and the tyrosinase activity index was determined from the following formula. In addition, a blank was obtained by performing the same operation using water instead of the extract. The results are shown in Table 1.
[チロシナーゼ活性指数]
(式中、”24は試験開始から24分間経過後の抽出液
が添加された溶液の吸光度、B24は試験開始から24
分間経過後の抽出液のかわりに水が添加された溶液の吸
光度、Toは試験開始直後の抽出液が添加された溶液の
吸光度、Boは試験開始直後の抽出液のかわりに水が添
加された溶液の吸光度を示す。)
■過酸化脂質生成抑制作用(ロダン・鉄性)0.5Mリ
ノール酸エタノール1.0ml、 0.2Mリン酸緩
衝液(pH7,0) fowlおよびエタノール9.0
mlをそれぞれ正確に秤量し、共栓つき三角フラスコ中
でよく振り混ぜた。この液に正確に秤量した抽出液の5
%水溶液5.0mlを加えてよく振り混ぜた。この液の
調製直後のものと40℃の恒温槽中で7日間放置したも
のについてそれぞれを0.1mlずつ正確に秤量し、7
5%エタノール4.7ml 30%チオシアン酸アンモ
ニウム溶液0.1mlおよび2XlO−2M塩化第一鉄
の3 、596塩酸溶液0.1mlを加えて充分に撹拌
して混合したのち、正確に3分間経過後の波長500n
iにおける吸光度を測定し、下式から過酸化物価指数を
求めた。また抽出液の代わりに水を用いて同様に操作し
たものをブランクとした。その結果を第1表に示す。[Tyrosinase activity index] (In the formula, 24 is the absorbance of the solution to which the extract was added 24 minutes after the start of the test, and B24 is the absorbance of the solution 24 minutes after the start of the test.
The absorbance of the solution in which water was added instead of the extract after a minute has elapsed, To is the absorbance of the solution in which the extract was added immediately after the start of the test, and Bo is the absorbance of the solution in which water was added instead of the extract immediately after the start of the test. Indicates the absorbance of the solution. ) ■ Lipid peroxide production inhibitory effect (rodan/iron) 0.5M linoleic acid ethanol 1.0ml, 0.2M phosphate buffer (pH 7.0) fowl and ethanol 9.0
Each ml was accurately weighed and mixed well in an Erlenmeyer flask with a stopper. Add 50% of the extract solution weighed accurately to this solution.
% aqueous solution was added thereto, and the mixture was thoroughly shaken. Accurately weigh 0.1 ml of each of the solution immediately after preparation and the solution that had been left in a constant temperature bath at 40°C for 7 days.
Add 4.7 ml of 5% ethanol, 0.1 ml of 30% ammonium thiocyanate solution, and 0.1 ml of 2XlO-2M 3,596 hydrochloric acid solution of ferrous chloride, mix thoroughly, and after exactly 3 minutes have elapsed. wavelength of 500n
The absorbance at i was measured, and the peroxide value index was determined from the following formula. In addition, a blank was obtained by performing the same operation using water instead of the extract. The results are shown in Table 1.
[過酸化物価指数コ
’ −TOX 100 (!Jci)B 7 B
。[Peroxide price index CO' -TOX 100 (!Jci) B 7 B
.
(式中、T7は試験開始から7日間経過後の抽出液か添
加された溶液の吸光度、B7は試験開始から7日間経過
後の抽出液が添加されていtjい溶液の吸光度、Toは
試験開始直後の抽出液が添加された溶液の吸光度、Bo
は試験開始直後の抽出液のかわりに水が添加された溶液
の吸光度を示す。)
処方例1 [クリーム]
[(A)成分] (部)流動
パラフィン 9.0パラフイン
5.0セタノール
2.0グリセリルモノステアレート
2.0ポリオキシエチレン囚ソルビタン
モノステアレート 5.0ブチルパラベ
ン 0.1[(B)成分]
調製例1でえられた抽出物 30.0グリセリン
5.0カルボキシメチルセルロ
ース 0.1メチルパラベン
0.1精製水 41.4[
(C)成分]
香 料
0,3上記(A)成分および(B)成分をそれぞれ
80”C以上に加熱後、かかる(A)成分および(B)
成分を混合撹拌した。これを5o″Cまで冷却後、上記
(C)成分を加えてさらに撹拌混合して均一なりリーム
を調製した。(In the formula, T7 is the absorbance of the extract or the solution added after 7 days from the start of the test, B7 is the absorbance of the solution without the extract added after 7 days from the start of the test, and To is the absorbance of the solution after 7 days from the start of the test. Absorbance of the solution immediately after adding the extract, Bo
indicates the absorbance of a solution in which water was added instead of the extract immediately after the start of the test. ) Prescription example 1 [Cream] [Component (A)] (Part) Liquid paraffin 9.0 Paraffin
5.0 cetanol
2.0 Glyceryl Monostearate
2.0 Polyoxyethylene sorbitan monostearate 5.0 Butylparaben 0.1 [Component (B)] Extract obtained in Preparation Example 1 30.0 Glycerin 5.0 Carboxymethylcellulose 0.1 Methylparaben
0.1 Purified water 41.4 [
(C) Ingredient] Fragrance
0,3 After heating the above (A) component and (B) component to 80"C or higher, the (A) component and (B) component
The ingredients were mixed and stirred. After cooling this to 5o''C, the above component (C) was added and further stirred and mixed to prepare a uniform ream.
処方例2[ローション]
[成分コ (部)エタノール
l090グリセリン
3.01.3−ブチレングリコール
2.0メチルパラベン 0
.2クエン酸 0.1クエン
酸ナトリウム 0.3カルボキシビニル
ポリマー 0.1調製例2でえられた抽出物
50,0香 料
微量精製水 全量がio
o、o部となる量
上記成分を混合して均一なローションを調製した。Prescription example 2 [Lotion] [Ingredients (Part) Ethanol 1090 Glycerin
3.01.3-Butylene glycol
2.0 Methylparaben 0
.. 2 Citric acid 0.1 Sodium citrate 0.3 Carboxyvinyl polymer 0.1 Extract obtained in Preparation Example 2
50,0 fragrance
Micro-purified water, the entire amount is io
A homogeneous lotion was prepared by mixing the above components in amounts of o and o parts.
処方例3[バック〕
[成分] (部)ポリビニルア
ルコール 15.0ヒドロキシメチルセルロ
ース 50プロピレングリコール
5.0エタ7ノール 10.0
メチルベラベン 0.1調製例3て
えられた抽出物 10.0香 料
微量精製水
全量力叫0O10部となる最
上記成分を混合撹拌して均一なバックを調製した。Formulation example 3 [Back] [Ingredients] (Part) Polyvinyl alcohol 15.0 Hydroxymethyl cellulose 50 Propylene glycol
5.0 ethanol 7nol 10.0
Methylbellaben 0.1 Extract obtained from Preparation Example 3 10.0 Flavor
micro purified water
A uniform bag was prepared by mixing and stirring the above-mentioned ingredients in a total amount of 10 parts.
処方例4 〔プレスパウダーコ
調製例4てえられた抽出物を凍結乾燥粉末で水分除去す
ることにより、凍結乾燥し、これをボールミルにより粉
砕して粉末(粒度約30μm以下)をえ、かかる粉末を
用いた。Formulation Example 4 [Preparation Example 4] The extract obtained in Preparation Example 4 is freeze-dried by removing water with a freeze-dried powder, and this is ground by a ball mill to obtain a powder (particle size of about 30 μm or less). was used.
[回収分] (部)ベンガラ
0.5葭酸化鋏
15黒酸化鉄
0.1酸化チ7二 10.0
ナイロンパウダー 4.0セリサイト
28.0マイカ
23.。[Collected amount] (part) red iron 0.5 yam oxidized scissors
15 black iron oxide
0.1 Chi oxide 72 10.0
Nylon powder 4.0 Sericite 28.0 Mica
23. .
タルク 25.0調製例4
でえられた
抽出物の凍結乾燥粉末 0.7[旧)成分]
スクワラン 1.0メチルポリ
シロキザン 4゜プロピルパラベン
o1デヒドロ酢酸
0.1流動パラフイン 2゜香
粗
微量上記CA、)成分および(B)成分をそれぞれ
混合撹拌し、かかる(A)成分および(B)成分を混合
したのち、200メノシニのタイラーメッシュの篩にか
けて金型に打型して均一なプレスパウダーを調製した。Talc 25.0 Preparation Example 4
Freeze-dried powder of the resulting extract 0.7 [Old) Ingredients] Squalane 1.0 Methylpolysiloxane 4゜Propylparaben
o1 dehydroacetic acid
0.1 liquid paraffin 2° fragrance
Coarse
After mixing and stirring a small amount of the above CA, component) and component (B), and mixing the component (A) and component (B), the mixture was passed through a 200 Menoshini Tyler mesh sieve and pressed into a mold to form a uniform press. A powder was prepared.
処方例5 [シャンプー]
調製例3でえられた抽出物を処方例4と同様の操作によ
り凍結乾燥し、粉砕してえられた粉末(粒度約30摩以
下)を用いた。Formulation Example 5 [Shampoo] The extract obtained in Preparation Example 3 was freeze-dried in the same manner as in Formulation Example 4, and the resulting powder (particle size of about 30 mm or less) was used.
[11i、分] (部)ラウ
リル硫酸トリエタノール
アミン 15.0ラウリン酸ジエ
タノール
ア ミ ド
5.0メチルパラベン
0.1プロピルパラベン
0.1調製例3でえられた
抽出物の凍結乾燥粉末 0.5香 料
微量精製水
全量が100.0部となる量
上記成分を混合撹拌して均一なシャンプーを調製した。[11i, min] (Part) Lauryl sulfate triethanolamine 15.0 Lauric acid diethanolamide
5.0 Methylparaben
0.1 propylparaben
0.1 Freeze-dried powder of the extract obtained in Preparation Example 3 0.5 Flavor
micro purified water
A uniform shampoo was prepared by mixing and stirring the above ingredients in amounts such that the total amount was 100.0 parts.
処方例6[ヘアーセットローション]
31B例2でえられた抽出物をスプレードライの操作に
より乾燥粉末化してえられた粉末(粒度的100−以下
)を用いた。Formulation Example 6 [Hair Set Lotion] A powder (particle size of 100- or less) obtained by drying the extract obtained in Example 2 of 31B by spray drying was used.
[成分] (部)トラガント
ガム 2.0グリセリン
1.0エタノール
20.0メチルパラベン 0.2調製
例2でえられた
抽出物の凍結乾燥粉末 0.5香 料
微量精製水
全量が100.0部となる量
上記成分を混合撹拌して均一なヘアーセットローション
をえた。[Ingredients] (Part) Gum tragacanth 2.0 Glycerin
1.0 ethanol
20.0 Methylparaben 0.2 Freeze-dried powder of the extract obtained in Preparation Example 2 0.5 Flavor
micro purified water
The above ingredients were mixed and stirred in such amounts that the total amount was 100.0 parts to obtain a uniform hair setting lotion.
処方例7 [ヘアーリンス]
調製例1でえられた抽出物を処方例6と同様の操作によ
り凍結乾燥し、粉砕して粉末(粒度約30摩以下)をえ
、かかる粉末を用いた。Formulation Example 7 [Hair Rinse] The extract obtained in Preparation Example 1 was freeze-dried in the same manner as in Formulation Example 6, and ground to obtain a powder (particle size of about 30 microns or less), and this powder was used.
[(A)成分〕 (部)ベヘ
ニルアルコール 0.2セタノール
1.5ステアリルトリメチル
アンモニウムクロライド 20グリセリルモノ
ステアレート
(自己乳化型)2゜
ヘキサラン
(共栄化学工業■製)1.0
調製例1でえられた
抽出物の凍結乾燥粉末 i、0[(B)成分コ
ヒドロキンエチルセルロース 1.0メチルパラ
ベン 0.2グリセリン
3゜精製水 8
7.9[(0成分コ
香 料
・0.2上記(A)成分および(B)成分をそれぞれ
80℃以上に加熱後、混合撹拌した。50’Cまで冷却
後、(C)成分を加えてさらに撹拌混合して均一なヘア
ーリンスを調製した。[Component (A)] (Part) Behenyl alcohol 0.2 cetanol
1.5 Stearyltrimethylammonium chloride 20 Glyceryl monostearate (self-emulsifying type) 2° Hexalan (manufactured by Kyoei Chemical Industry Co., Ltd.) 1.0 Freeze-dried powder of the extract obtained in Preparation Example 1 i, 0 [(B) Ingredients: Cohydroquine ethylcellulose 1.0 Methylparaben 0.2 Glycerin
3゜Purified water 8
7.9 (0 ingredients fragrance)
-0.2 The above (A) component and (B) component were each heated to 80° C. or higher, and then mixed and stirred. After cooling to 50'C, component (C) was added and further stirred and mixed to prepare a uniform hair rinse.
処方例8〔浴剤]
調製例3でえられた抽出物を処方例6と同様の操作によ
り凍結乾燥し、粉砕してえられた粉末(粒度的100−
以下)を用いた。Formulation Example 8 [Bath Salt] The extract obtained in Preparation Example 3 was freeze-dried in the same manner as in Formulation Example 6, and a powder obtained by pulverization (particle size: 100-
(below) was used.
[成分] (部)硫酸ナトリウ
ム 47.0炭酸水素ナトリウム
47.0調製例3てえられた
抽出物の凍結乾燥粉末 6.0香 料
微量上記成分を
混合撹拌して均一な浴剤を調製した。[Ingredients] (Part) Sodium sulfate 47.0 Sodium hydrogen carbonate
47.0 Preparation Example 3 Freeze-dried powder of the obtained extract 6.0 Flavor
A uniform bath agent was prepared by mixing and stirring trace amounts of the above components.
比較処方例1
調製例1でえられた抽出物の代わりに精製水を用いたほ
かは処方例1と同様にしてクリームを調製した。Comparative Formulation Example 1 A cream was prepared in the same manner as Formulation Example 1 except that purified water was used instead of the extract obtained in Preparation Example 1.
比較処方例2
調製例2てえられた抽出物の代わりに’fi’i製水を
用いたほかは処方例2と同様にしてローションを調製し
た。Comparative Prescription Example 2 A lotion was prepared in the same manner as Preparation Example 2 except that 'fi'i water was used instead of the extract obtained in Preparation Example 2.
比較処方例3
調製例3でえられた抽出物の代わりに精製水を用いたほ
かは処方例3と同様にしてバックを調製した。Comparative Formulation Example 3 A bag was prepared in the same manner as Formulation Example 3 except that purified water was used instead of the extract obtained in Preparation Example 3.
比較処方例4
調製例3でえられた抽出物の代わりに精製水を用いたほ
かは、処方例5と同様にしてシャンプーを調製した。Comparative Formulation Example 4 A shampoo was prepared in the same manner as Formulation Example 5, except that purified water was used instead of the extract obtained in Preparation Example 3.
比較処方例5
調製例2でえられた抽出物の代わりに精製水を用いたほ
かは処方例6と同様にしてヘアーセットローションを調
製した。Comparative Formulation Example 5 A hair setting lotion was prepared in the same manner as Formulation Example 6 except that purified water was used instead of the extract obtained in Preparation Example 2.
比較処方例6
調製例1でえられた抽出物の代わりに精製水を用いたほ
かは処方例7と同様にしてヘアーリンスを調製した。Comparative Formulation Example 6 A hair rinse was prepared in the same manner as Formulation Example 7 except that purified water was used instead of the extract obtained in Preparation Example 1.
比較処方例7
調製例3でえられた抽出物の代わりに精製水を用いたほ
かは処方例8と同様にして浴剤を調製した。Comparative Formulation Example 7 A bath agent was prepared in the same manner as Formulation Example 8 except that purified water was used instead of the extract obtained in Preparation Example 3.
実施例1
処方例1〜3および比較処方例1〜3でえられた化粧料
についてそれぞれ以下に示すモニターテストを行なった
。その結果を第2表に示す。Example 1 The following monitor tests were conducted on the cosmetics obtained in Formulation Examples 1 to 3 and Comparative Formulation Examples 1 to 3. The results are shown in Table 2.
(モニターテスト)
無作為に抽出した年齢18〜55歳の女性100名を対
象として各化粧料を顔面頬部の皮膚に塗布したときのモ
イスチャー効果、エモリエント効果および肌のつやにつ
いて以下の判定基準にもとづき、評価を行なった。(Monitor test) The moisturizing effect, emollient effect, and skin luster when each cosmetic was applied to the skin of the face and cheeks were evaluated according to the following criteria for 100 randomly selected women aged 18 to 55. Based on this, we conducted an evaluation.
[モイスチャー効果コ
A:非常にしっとりしている
B:なんとなくしっとりしている
C:普通
り二あまりしっとりした感じがない
E:まったくしっとりした感じがない
[エモリエント効果]
A:非常に柔軟で感触がよい
B:なんとなく柔軟で感触がよい
C:普通
D:あまり柔軟さを感じず、感触がよくないE:まった
く柔軟さを感じず、感触がよくな[肌のっや]
A:非常につややかになった
B:なんとなくつややかになった
C:変化なし
DニなんとなくつややかさがなくなったE:明らかにつ
ややかさがなくなった
なお、モニターテストの結果、皮膚に異常を訴えた者は
いなかった。[Moisture effect A: Very moist B: Somehow moist C: Average or not very moist E: No moist feeling at all [Emollient effect] A: Very soft and pleasant to the touch Good B: Somehow soft and has a good feel C: Average D: Doesn't feel very flexible and has a good feel E: Doesn't feel flexible at all and has a good feel [skin smoothness] A: Very shiny B: Somehow became shiny C: No change D Somehow lost luster E: Obviously lost luster Furthermore, as a result of the monitor test, no one complained of any skin abnormality.
[以下余白]
実施例2
処方例5〜7および比較処方例4〜6でえられた頭髪用
化粧品についてそれぞれ以下に示すハーフヘッドテスト
を行なった。その結果を第3表に示す。[Blank below] Example 2 The hair cosmetics obtained in Formulation Examples 5 to 7 and Comparative Formulation Examples 4 to 6 were subjected to the following half-head test. The results are shown in Table 3.
(ハーフヘッドテスト)
無作為に抽出した年令18〜60歳の男性20名を対象
として各頭髪用化粧料を頭髪に1日2回、30日間使用
したのちの頭髪のつややかさ、しっとり感およびくし通
りについて以下の判定基準に基づき、評優を行なった。(Half-head test) 20 randomly selected men between the ages of 18 and 60 used each hair cosmetic twice a day for 30 days. Kushidori was evaluated based on the following criteria.
【つややかさ]
A:非常につややかになった
B:なんとなくつややかになった
C:変化なし
D:なんとなくつややかさがなくなったE:まったくつ
ややかさがなくなった
[しっとりg]
A:非常にしっとりして感じがよくなったB:なんとな
くしっとりして感じがよくなつC:変化なし
D二あまりしっとり感が感じられなくなったE:まった
くしっとり感が感じられなくなった
[<シ通すコ
A:非常によくなった
B:なんとなくよくなった
C:変化なし
D:なんとなくわるくなった
E:まったくわるくなった
なお、ハーフヘッドテストの結果、頭髪や頭皮に異常を
訴えた者はいなかった。[Shininess] A: Very shiny B: Somehow shiny C: No change D: Somehow lost gloss E: No shiny at all [Moist G] A: Very moist It feels better B: It feels moister and better C: There is no change D2 It doesn't feel moist at all E: It doesn't feel moist at all B: Somewhat improved C: No change D: Somewhat worse E: Completely worse In addition, as a result of the half-head test, no one complained of any abnormalities with their hair or scalp.
[以下余白]
実施例3
処方例8および比較処方例7でえられた浴剤についてそ
れぞれ以下に示すモニターテストを行なった。その結果
を第4表に示す。[Left below] Example 3 The following monitor tests were conducted on the bath additives obtained in Formulation Example 8 and Comparative Formulation Example 7. The results are shown in Table 4.
(モニターテスト)
無作為に抽出した年齢30〜60歳の女性20名を対象
として入浴中に各浴剤を湯20ONに対して25g使用
したばあいに、入浴後20℃、湿度65%における部屋
で15分間休息後の体温の保温効果について以下の判定
基準にもとづいて評価を行なった。(Monitor test) 20 randomly selected women aged 30 to 60 were tested in a room at 20°C and 65% humidity after bathing when 25g of each bath additive was used per 20ON of hot water. The effectiveness of keeping body temperature after a 15-minute rest was evaluated based on the following criteria.
(保温効果)
A:非常に暖かさを感じる
B:心地よい暖かさを感じる
C:普通
D=わずかに肌寒さを感じる
E:肌寒い
なお、モニターテストの結果、皮膚に異常を訴えた者は
いなかった。(Heat retention effect) A: Feels very warm B: Feels pleasantly warm C: Average D = Feels slightly chilly E: Chilly However, as a result of the monitor test, no one complained of any skin abnormalities. .
第 4 表 効果を奏する。No. 4 table be effective.
また、本発明の化粧料は、浴剤として用いたばあいには
、入浴中および入浴後の体温の保温効果にすぐれたもの
である。Furthermore, when the cosmetic of the present invention is used as a bath agent, it has an excellent effect of keeping body temperature during and after bathing.
さらには、本発明の化粧料は、頭髪用の化粧料として用
いたばあいには、枝毛や切れ毛の防止、頭髪保護などの
効果を奏する。Furthermore, when the cosmetic of the present invention is used as a hair cosmetic, it exhibits effects such as preventing split ends and hair breakage and protecting the hair.
[発明の効果][Effect of the invention]
Claims (1)
化粧料。 2 抽出物が、蛋白分解酵素処理が施されたものである
請求項1記載の化粧料。[Claims] 1. A cosmetic containing an extract obtained from the internal organs of gastropods. 2. The cosmetic according to claim 1, wherein the extract has been treated with a proteolytic enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9256190A JP2963136B2 (en) | 1990-04-07 | 1990-04-07 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9256190A JP2963136B2 (en) | 1990-04-07 | 1990-04-07 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03291208A true JPH03291208A (en) | 1991-12-20 |
JP2963136B2 JP2963136B2 (en) | 1999-10-12 |
Family
ID=14057839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9256190A Expired - Lifetime JP2963136B2 (en) | 1990-04-07 | 1990-04-07 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2963136B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117898959A (en) * | 2024-01-16 | 2024-04-19 | 华泽睿孚生物技术(广州)有限公司 | Tightening and anti-aging composition and preparation method and application thereof |
-
1990
- 1990-04-07 JP JP9256190A patent/JP2963136B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117898959A (en) * | 2024-01-16 | 2024-04-19 | 华泽睿孚生物技术(广州)有限公司 | Tightening and anti-aging composition and preparation method and application thereof |
Also Published As
Publication number | Publication date |
---|---|
JP2963136B2 (en) | 1999-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3171637B2 (en) | Anti-aging cosmetics | |
JP3711377B2 (en) | Emulsifier, emulsified cosmetic and production method thereof | |
JP3576200B2 (en) | Whitening cosmetics | |
JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
JP2008545003A (en) | Improvements in skin or hair care | |
JP2003048846A (en) | Collagenase inhibitor and antiaging cosmetic | |
JPH08325130A (en) | Cosmetic | |
JP3513872B2 (en) | External preparation for skin | |
JP4824933B2 (en) | Cosmetics | |
JP3061295B2 (en) | Cosmetics | |
JP2971549B2 (en) | Cosmetics | |
JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
JP3044690B2 (en) | Cosmetics | |
JP2011195539A (en) | Elastase activity inhibitor | |
JP2604782B2 (en) | Cosmetics | |
JP2001212445A (en) | Emulsifying agent | |
JP2002128632A (en) | Cosmetic | |
JPH03291208A (en) | Cosmetic | |
JP3818998B2 (en) | Whitening cosmetics | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
KR100414903B1 (en) | Cosmetic composition containing medical plant complex extracts with antiwrinkle and whitening effect | |
JP2003212897A (en) | Fish collagen and cosmetic with the formulated fish collagen | |
JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
JP2015151388A (en) | cosmetic |